Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Premium Peptides Australia from a Trusted Supplier Quality matters when selecting a peptide supplier
Further investigation into how noradrenergic degeneration interacts with AD pathology and contributes to cognitive decline, may help explain why some LLD are at heightened risk for dementia and may identify those most likely to benefit from noradrenergic-targeted treatments
How Long Does Bacteriostatic Water Last After Opening
Composition & Format Active: FOXO4 peptide (FOXO4-DRI analog) Strength: 10 mg FOXO4 per vial Format: White lyophilized peptide powder Standard kit: 10 vials per kit for wholesale orders Origin: China-based factory, export-ready documentation available on request Key Features for Wholesale Buyers High-purity (99%) FOXO4 peptide for senolytic and anti-aging research projects Factory-direct supply with flexible OEM/ODM and labeling options Consistent quality across batches, suitable for long-term study designs Competitive wholesale pricing for bulk kits and repeat orders Packaging & Ordering Standard packaging: 10 mg/vial, 10 vials per kit in sealed plastic trays Each tray is protected with bubble wrap and export carton for secure international shipping Typical dispatch updates provided within 3 business days after payment confirmation For bulk pricing, OEM labels, or combined peptide orders, please contact our sales team directly Storage & Handling Store FOXO4 peptide kits in a sealed container at 28 C , away from light and moisture For long-term storage, keep vials tightly closed and minimize freezethaw cycles Use reconstituted solutions promptly under appropriate laboratory conditions Related Products Follistatin-344 muscle & tissue support peptide kit LL-37 immune & inflammation support peptide kit Blend TB-500 5 mg + BPC-157 5 mg + GHK-Cu 50 mg advanced healing peptide kit Compliance Notes THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY
Studies suggest that ALS patients exhibit lower expression levels of NPGPx compared to unaffected individuals, and mice deficient in NPGPx develop ALS-like phenotypes
